Zevra Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of SDX in Patients With Idiopathic Hypersomnia (IH) (NCT05668754) | Zevra Therapeutics | 2022-12-28 |
| KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD (NCT03460652) | Zevra Therapeutics | 2018-03-13 |
| KP415 Classroom Study in Children (6-12 Years of Age) With ADHD (NCT03292952) | Zevra Therapeutics | 2017-12-20 |
Track Zevra Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.